Longitudinal Molecular Analysis of Tumor Exome and Transcriptome to Evaluate Clonal Evolution and Identify Novel Therapeutic Targets in Thymoma
Open Access
- 1 July 2023
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in JCO Precision Oncology
- Vol. 7 (7) , e2300107
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trialThe Lancet Oncology, 2020
- Anti-EGFR target therapy in advanced thymic epithelial tumors.Journal of Clinical Oncology, 2019
- APOBEC Mutagenesis and Copy-Number Alterations Are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic TumorsCell Reports, 2019
- The Integrated Genomic Landscape of Thymic Epithelial TumorsCancer Cell, 2018
- AB009. OS02.03. Phase II trial of cetuximab and chemotherapy followed by surgical resection for locally advanced thymomaMediastinum, 2017
- Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trialThe Lancet Oncology, 2015
- Copy Number Aberrations of Genes Regulating Normal Thymus Development in Thymic Epithelial TumorsClinical Cancer Research, 2013
- Thymoma and Thymic Carcinoma: Molecular Pathology and Targeted TherapyJournal of Thoracic Oncology, 2010
- Protein expression and gene amplification of epidermal growth factor receptor in thymomasCancer, 2005
- Epidermal growth factor receptor expression in invasive thymomaJournal of Cancer Research and Clinical Oncology, 2002